As vaccine production falls behind schedule, and the European Union lags in inoculating people, Brussels and London are lobbing threats and accusations at each other.
Tag: Drugs (Pharmaceuticals)
In Israel, Infections Drop Sharply After One Shot of Vaccine
Initial studies show a significant drop in infections and hospitalizations after just one dose, and very few cases after two. Experts caution that the results are preliminary.
Ukraine Ended Secret Government Spending. Vaccine Makers Now Demand It.
Seeking to secure vital supplies, the authorities in the country maneuvered around anticorruption rules that require public disclosure of contracts.
Eli Lilly Claims Drug Prevents Coronavirus Infection in Nursing Homes
A monoclonal antibody protected residents and staff members in facilities where the virus had appeared.
Drug Prevents Coronavirus Infection in Nursing Homes, Maker Claims
A monoclonal antibody protected residents and staff members in facilities where the virus had appeared.
India’s Covid-19 Vaccine Drive Begins
One of the world’s largest inoculation programs is set to begin on Saturday, but experts have questioned the data behind one of the country’s two vaccines — and patients don’t get to pick their shot.
After Quick Vaccine Success, Israel Faces New Virus Woes
Israel imposed a tighter lockdown as coronavirus infections soared, the variant spread, vaccines were running out and a debate erupted over the country’s responsibility to the Palestinians.
India Approves Oxford-AstraZeneca Covid-19 Vaccine and 1 Other
The approvals, which include a shot developed by Bharat Biotech, an Indian pharmaceutical company, begin a vast campaign to inoculate the hard-hit nation’s 1.3 billion people.
For Covid-19 Vaccines, Some Are Too Rich — and Too Poor
Global inequality is shaping which countries get vaccines first. In South Africa, people’s best chance for vaccines anytime soon is to join an experimental trial.
Covid Antibody Drugs Go Unused as Need Soars
While such treatments are promising, their use has been slowed by testing lags, overwhelmed hospitals and a perception the therapies are only for well-connected people.